Therefore, we conduct a clinical-trial study to demonstrate the potency of colchicine and late PCI to regulate the progression of MMP-9, NOX2, and TGF-β1 in stable MI patients who are done by late PCI and Optimal Medical Treatment (OMT) only. This evidence concerns the gene MMP9 and myocardial infarction.